• 
  Gilles Houvenaeghel, Alexandre De Nonneville, Monique Cohen, Jean-Marc Classe, Fabien Reyal, et al.. Contribution of endocrine therapy in oestrogen receptor-positive pT1a-b breast cancer: Results of a retrospective study. European Journal of Cancer, 2022, 176, pp.58-69. ⟨10.1016/j.ejca.2022.08.027⟩. ⟨hal-04084967⟩
• 
  Estelle Vallier, Sylvain Besle. Industrialisation de la recherche clinique en cancérologie. Sociologie du Travail, 2023, 65 (1), pp.42879. ⟨10.4000/sdt.42879⟩. ⟨hal-04164702⟩
• 
  Jordi Remon, Nicolas Girard, Silvia Novello, Javier de Castro, Laurence Bigay-Game, et al.. PECATI: A Multicentric, Open-Label, Single-Arm Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab and Lenvatinib in Pretreated B3-Thymoma and Thymic Carcinoma Patients. Clinical Lung Cancer, 2021, ⟨10.1016/j.cllc.2021.07.008⟩. ⟨hal-03524401⟩
• 
  Violaine Tran Quang, Benjamin Podvin, Christophe Desterke, Sihem Tarfi, Quentin Barathon, et al.. TET2 mutational status affects myelodysplastic syndrome evolution to chronic myelomonocytic leukemia. Haematologica, 2023, 108 (11), pp.3135-3141. ⟨10.3324/haematol.2022.282528⟩. ⟨hal-04438417⟩
• 
  Gonzalo Recondo, Linda Mahjoubi, Aline Maillard, Yohann Loriot, Ludovic Bigot, et al.. Feasibility and first reports of the MATCH-R repeated biopsy trial at Gustave Roussy. npj Precision Oncology, 2020, 4 (1), pp.27. ⟨10.1038/s41698-020-00130-7⟩. ⟨hal-04438616⟩
• 
  Michael Baumann, Julio Celis, Ulrik Ringborg, Manuel Heitor, Anton Berns, et al.. Engaging European society at the forefront of cancer research and care. Molecular Oncology, 2023, 17 (6), pp.925-945. ⟨10.1002/1878-0261.13423⟩. ⟨hal-04438476⟩
• 
  Evandro Bezerra, Terra Lasho, Christy Finke, Antoine Saliba, Michelle Elliott, et al.. CSF3R T618I mutant chronic myelomonocytic leukemia (CMML) defines a proliferative CMML subtype enriched in ASXL1 mutations with adverse outcomes. Blood Cancer Journal, 2021, 11 (3), pp.54. ⟨10.1038/s41408-021-00449-9⟩. ⟨hal-04438590⟩
• 
  William Vainchenker, Emilie Leroy, Laure Gilles, Caroline Marty, Isabelle Plo, et al.. JAK inhibitors for the treatment of myeloproliferative neoplasms and other disorders. F1000Research, 2018, 7, pp.82. ⟨10.12688/f1000research.13167.1⟩. ⟨hal-04429901⟩
• 
  Krzysztof Kubiak, Frank Wien, Indresh Yadav, Nykola Jones, Søren Vrønning Hoffmann, et al.. Amyloid-like Hfq interaction with single-stranded DNA: involvement in recombination and replication in Escherichia coli. QRB Discovery, 2022, 3, pp.e15. ⟨10.1017/qrd.2022.15⟩. ⟨hal-04353804⟩
• 
  Fidel Antonio Castro-Smirnov, Olivier Pietrement, Pilar Aranda, Jean-Rémi Bertrand, Jeanne Ayache, et al.. Physical interactions between DNA and sepiolite nanofibers, and potential application for DNA transfer into mammalian cells. Scientific Reports, 2016, 6, pp.36341. ⟨10.1038/srep36341⟩. ⟨hal-03065105⟩
• 
  Fidel Antonio Castro-Smirnov, Jeanne Ayache, Jean-Rémi Bertrand, Elodie Dardillac, Eric Le Cam, et al.. Cellular uptake pathways of sepiolite nanofibers and DNA transfection improvement. Scientific Reports, 2017, 7 (1), pp.5586. ⟨10.1038/s41598-017-05839-3⟩. ⟨hal-03065103⟩
• 
  Michalis Fragkos, Viviana Barra, Tom Egger, Benoit Bordignon, Delphine Lemacon, et al.. Dicer prevents genome instability in response to replication stress. Oncotarget, 2019, 10 (43), pp.4407-4423. ⟨10.18632/oncotarget.27034⟩. ⟨hal-04442048⟩
• 
  Claire Bouthier de La Tour, Martine Mathieu, Laura Meyer, Pauline Dupaigne, Fanny Passot, et al.. In vivo and in vitro characterization of DdrC, a DNA damage response protein in Deinococcus radiodurans bacterium. PLoS ONE, 2017, 12 (5), pp.e0177751. ⟨10.1371/journal.pone.0177751⟩. ⟨hal-02187767⟩
• 
  Nicolas Duployez, Loïc Vasseur, Rathana Kim, Laëtitia Largeaud, Marie Passet, et al.. UBTF tandem duplications define a distinct subtype of adult de novo acute myeloid leukemia. Leukemia, 2023, 37 (6), pp.1245-1253. ⟨10.1038/s41375-023-01906-z⟩. ⟨hal-04541085⟩
• 
  Ewa Blaszczak, Emeline Pasquier, Gaëlle Le Dez, Adrian Odrzywolski, Natalia Lazarewicz, et al.. Dissecting ubiquitylation and DNA damage response pathways in the yeast Saccharomyces cerevisiae using a proteome-wide approach. Molecular and Cellular Proteomics, 2024, Molecular and Cellular Proteomics, 23 (1), pp.100695. ⟨10.1016/j.mcpro.2023.100695⟩. ⟨hal-04355212⟩
• 
  Thomas Kaley, Mehdi Touat, Vivek Subbiah, Antoine Hollebecque, Jordi Rodon, et al.. BRAF Inhibition in BRAF V600 -Mutant Gliomas: Results From the VE-BASKET Study. Journal of Clinical Oncology, 2018, 36 (35), pp.3477-3484. ⟨10.1200/JCO.2018.78.9990⟩. ⟨hal-04541090⟩
• 
  Prashanth Ashok Kumar, Maryam Karimi, Alina Basnet, Lesley K. Seymour, Robert Arthur Kratzke, et al.. Association of Molecular Profiles and Mutational Status With Distinct Histological Lung Adenocarcinoma Subtypes. An Analysis of the LACE-Bio Data. Clinical Lung Cancer, 2023, 24 (6), pp.528-540. ⟨10.1016/j.cllc.2023.06.002⟩. ⟨hal-04229530⟩
• 
  Laurence Brugières, Nathalie Cozic, Roch Houot, Charlotte Rigaud, David Sibon, et al.. Efficacy and safety of crizotinib in ALK-positive systemic anaplastic large-cell lymphoma in children, adolescents, and adult patients: results of the French AcS-crizotinib trial. European Journal of Cancer, 2023, 191, pp.112984. ⟨10.1016/j.ejca.2023.112984⟩. ⟨hal-04228222⟩
• 
  Alice Boilève, Matthieu Faron, Sarah Fodil-Cherif, Arnauld Bayle, Livia Lamartina, et al.. Molecular profiling and target actionability for precision medicine in neuroendocrine neoplasms: real-world data. European Journal of Cancer, 2023, 186, pp.122-132. ⟨10.1016/j.ejca.2023.03.024⟩. ⟨hal-04106320⟩
• 
  Pauline Rimmelé, Michela Esposito, Laure Delestré, Jean-Hugues Guervilly, Maya Ridinger-Saison, et al.. The Spi1/PU.1 transcription factor accelerates replication fork progression by increasing PP1 phosphatase in leukemia. Oncotarget, 2017, 8 (23), ⟨10.18632/oncotarget.16183⟩. ⟨hal-02424493⟩

2 202

2 201